Diverse human disorders, including the majority of neurodegenerative diseases, are thought to arise from the misfolding and aggregation of protein. We have recently described a novel technology to amplify cyclically misfolded proteins in vitro. This procedure, named protein misfolding cyclic amplification (PMCA), is conceptually analogous to DNA amplification by PCR and has tremendous implications for research and diagnosis. The PMCA concept has been proved on the amplification of prions implicated in the pathogenesis of transmissible spongiform encephalopathies. In this article we describe the rational behind PMCA and some of the many potential applications of this novel technology.
In large part, the study of brain electrophysiology now consists of nearly distinct fields: averaged event-related potentials (ERPs), the ongoing electroencephalogram (EEG), local field potentials (LFPs) and intracellular dynamics (most commonly, spike rate or timing) (Fig. 1 ). Of these, the two extreme subfields (ERPs and single-cell spike histograms) have been dominant, isolated from each other by differences in spatial scale, recording subjects and, in part, by modeling based on simple averaging methods. Our recent paper 
